This, in turn, may lead to the downregulation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway in cancer cells [10]. The gene discussed is AKT1; the disease is cancer.